Lv11
48 积分 2025-09-19 加入
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
10分钟前
待确认
Targeting the DNA methylation-H3K27me3 switch reverses castration resistance and immunosuppression via ADAMTS1-driven collagenolysis
2个月前
已完结
微环境重塑所需促进剂的时空传递推动脊髓损伤后神经再生
1年前
已完结